CD8A and neoplasm: In the context of anti‐tumour immunity, numerous mouse studies have established a key role for cDC1s, notably in their ability to cross‐present tumour‐derived antigens to CD8+ T cells and elicit cytotoxic responses against tumour cells [1, 2].